Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03832790 · ClinicalTrials.gov registry record
Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 23
- Enrollment target
NCT03832790: Completed study, sponsored by University of Colorado, Denver.
NCT03832790 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03832790 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Despite advancements in care, most adolescents with T1D have higher BMI and significantly higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2. Thus, alternative approaches to improve and maintain glycemic control, IR, and BMI for adolescents with T1D are urgently needed. This proposal moves beyond the current insulin and carbohydrate counting-focused lifestyle change paradigm to focus on sleep and circadian misalignment, which will allow for identification of new mechanisms that can be directly translated into future intervention and prevention trials. The goal of the current study is to utilize multiple objective measures of sleep duration, timing (actigraphy), and circadian rhythm (melatonin) in adolescents with type 1 diabetes (T1D; N = 40) and examine relationships with glycemic control, IR, vascular health, and BMI. Further, qualitative methodology will be used to identify barriers and facilitators to healthy sleep in adolescents with T1D.
Primary Outcome
HbA1c
Interventions
- OTHER observation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-12-04 |
| Est. Completion | 2023-06-30 |
What the finished NCT03832790 record still lists
NCT03832790 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which observation is the first listed.
NCT03832790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03832790 about?
NCT03832790 is a clinical study titled "Sleep, Glycemic Control, and Insulin Resistance in Adolescents With Type 1 Diabetes". Despite advancements in care, most adolescents with T1D have higher BMI and significantly higher HbA1c than recommended and are markedly IR, placing them at increased risk for CVD1,2. Thus, alternative approaches to improve and maintain glycemic control, IR, and BMI for adolescents with T1D are urge...
What is the current status of trial NCT03832790?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2019-12-04. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03832790?
The interventions under investigation include: observation (OTHER).
Who is sponsoring clinical trial NCT03832790?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI